Works matching AU KRENNING, E. P.

Results: 33

DOTA-NOC, A high affinity ligand of the somatostatin receptor subtypes 2, 3 and 5 for radiotherapy.

Published in:

Journal of Labelled Compounds & Radiopharmaceuticals, 2001, v. 44, p. S697, doi. 10.1002/jlcr.25804401246

By:

Schmitt, J. S.;
Wild, D.;
Ginj, M.;
Reubi, J. C.;
Waser, B.;
de Jong, M.;
Bernard, B. F.;
Krenning, E. P.;
Mäcke, H. R.

Publication type:

Article

In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand.

Published in:

Clinical Endocrinology, 1996, v. 45, n. 6, p. 755, doi. 10.1046/j.1365-2265.1996.8650876.x

By:

De Herder, W. W.;
Reijs, A. E. M.;
Kwekkeboom, D. J.;
Hofland, L. J.;
Nobels, F. R. E.;
Oei, H. Y.;
Krenning, E. P.;
Lamberts, S. W. J.

Publication type:

Article

The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism.

Published in:

Clinical Endocrinology, 1993, v. 39, n. 5, p. 499, doi. 10.1111/j.1365-2265.1993.tb02401.x

By:

Docter, R.;
Krenning, E. P.;
Jong, M.;
Hennemann, G.

Publication type:

Article

The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle-aged women: associations with serum lipids.

Published in:

Clinical Endocrinology, 1993, v. 39, n. 3, p. 275, doi. 10.1111/j.1365-2265.1993.tb02366.x

By:

Geul, K. W.;
Sluisveld, I. L. L.;
Grobbee, D. E.;
Docter, R.;
Bruyn, A. M.;
Hooykaas, H.;
Merwe, J. P.;
Hemert, A. M.;
Krenning, E. P.;
Hennemann, G.;
Weber, R. F. A.

Publication type:

Article

A case of antibody formation against octreotide visualized with.

Published in:

Clinical Endocrinology, 1993, v. 39, n. 2, p. 239, doi. 10.1111/j.1365-2265.1993.tb01780.x

By:

Kwekkeboom, D. J.;
Assies, J.;
Holland, L. J.;
Reubi, J. C.;
Lamberts, S. W. J.;
Krenning, E. P.

Publication type:

Article

CELLULAR AND HUMORAL IMMUNITY IN PATIENTS WITH HYPERTHYROID GRAVES' DISEASE BEFORE, DURING AND AFTER ANTITHYROID DRUG TREATMENT.

Published in:

Clinical Endocrinology, 1987, v. 26, n. 4, p. 385, doi. 10.1111/j.1365-2265.1987.tb00795.x

By:

OUWERKERK, B. M.;
KRENNING, E. P.;
DOCTER, R.;
BOS, G.;
OUDENAREN, A.;
BENNER, R.;
HENNEMANN, G.

Publication type:

Article

INHERITED THYROXINE EXCESS: A SERUM ABNORMALITY DUE TO AN INCREASED AFFINITY FOR MODIFIED ALBUMIN.

Published in:

Clinical Endocrinology, 1981, v. 15, n. 4, p. 363, doi. 10.1111/j.1365-2265.1981.tb00676.x

By:

DOCTER, R.;
BOS, G.;
KRENNING, E. P.;
FEKKES, D.;
VISSER, T. J.;
HENNEMANN, G.

Publication type:

Article

The effect of etanercept on Graves' ophthalmopathy: a pilot study.

Published in:

Eye (0950-222X), 2005, v. 19, n. 12, p. 1286, doi. 10.1038/sj.eye.6701768

By:

Paridaens, D.;
van den Bosch, W. A.;
van der Loos, T. L.;
Krenning, E. P.;
van Hagen, P. M.

Publication type:

Article

Tumor Response Assessment to Treatment with [177Lu-DOTA0,Tyr3]Octreotate in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Differential Response of Bone Versus Soft Tissue Lesions.

Published in:

Neuroendocrinology, 2012, v. 96, p. 65

By:

Van Vliet, E. I.;
Hermans, J. J.;
De Ridder, M. A.;
Teunissen, J. J.;
Kam, B. L.;
De Krijger, R. R.;
Krenning, E. P.;
Kwekkeboom, D. J.

Publication type:

Article

Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours.

Published in:

Neuroendocrinology, 2004, v. 80, n. 6, p. 394, doi. 10.1159/000085237

By:

Plöckinger, U.;
Rindi, G.;
Arnold, R.;
Eriksson, B.;
Krenning, E. P.;
De Herder, W. W.;
Goede, A.;
Caplin, M.;
Wiedenmann, B.;
Öberg, K.;
Reubi, J. C.;
Nilsson, O.;
Delle Fave, G.;
Ruszniewski, P.;
Ahlman, H.

Publication type:

Article

Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours.

Published in:

British Journal of Surgery, 2001, v. 88, n. 1, p. 31, doi. 10.1046/j.1365-2168.2001.01644.x

By:

Slooter, G. D.;
Mearadji, A.;
Breeman, W. A. P.;
Marquet, R. L.;
de Jong, M.;
Krenning, E. P.;
van Eijck, C. H. J.

Publication type:

Article

FDG SPECT in the assessment of myocardial viability.

Published in:

European Heart Journal, 1997, v. 18, n. suppl_D, p. 124, doi. 10.1093/eurheartj/18.suppl_D.124

By:

Bax, J.J.;
Valkema, R.;
Visser, F. C.;
van Lingen, A.;
Cornel, J. H.;
Poldermans, D.;
Rambaldi, R.;
Krenning, E. P.;
Fioretti, P. M.

Publication type:

Article

Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 3, p. 704, doi. 10.1007/s00259-018-4158-1

By:

van der Zwan, W. A.;
Brabander, T.;
Kam, B. L. R.;
Teunissen, J. J. M.;
Feelders, R. A.;
Hofland, J.;
Krenning, E. P.;
de Herder, W. W.

Publication type:

Article

Somatostatin and the immune and haematopoetic system; a review.

Published in:

European Journal of Clinical Investigation, 1994, v. 24, n. 2, p. 91, doi. 10.1111/j.1365-2362.1994.tb00972.x

By:

HAGEN, P. M. VAN;
KRENNING, E. P.;
KWEKKEBOOM, D. J.;
REUBI, J. C.;
ANKER-LUGTENBURG, Vd. P. J.;
LÖWENBERG, B.;
LAMBERTS, S. W. J.

Publication type:

Article

in vitro and in vivo detection of somatostatin receptors in human malignant lymphomas.

Published in:

International Journal of Cancer, 1992, v. 50, n. 6, p. 895, doi. 10.1002/ijc.2910500613

By:

Reubi, J. C.;
Waser, B.;
Van Hagen, M.;
Lamberts, S. W. J.;
Krenning, E. P.;
Gebbers, J.-O.;
Laissue, A. J.

Publication type:

Article

Somatostatin receptor scintigraphy in the initial staging of Hodgkin's disease.

Published in:

British Journal of Haematology, 1996, v. 93, n. 1, p. 96, doi. 10.1046/j.1365-2141.1996.443986.x

By:

Van Den Anker-Lugtenburg, P. J.;
Krenning, E. P.;
Oei, H. Y.;
Van Hagen, M. P.;
Gerrits, C. J. H.;
Reubi, J. C.;
Lamberts, S. W. J.;
Löwenberg, B.

Publication type:

Article

Somatostatin analogue scintigraphy of malignant lymphomas.

Published in:

British Journal of Haematology, 1993, v. 83, n. 1, p. 75, doi. 10.1111/j.1365-2141.1993.tb04634.x

By:

Vanhagen, P. M.;
Krenning, E. P.;
Reubi, J. C.;
Mulder, A. H.;
Bakker, W. H.;
Oei, H. Y.;
Löwenberg, B.;
Lamberts, S. W. J.

Publication type:

Article

Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 7, p. 1257, doi. 10.1007/s00259-011-1775-3

By:

Schroeder, Rogier P. J.;
Weerden, W. M.;
Krenning, E. P.;
Bangma, C. H.;
Berndsen, S.;
Grievink-de Ligt, C. H.;
Groen, H. C.;
Reneman, S.;
Blois, E.;
Breeman, W. A. P.;
Jong, M. de

Publication type:

Article

Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2007, v. 34, n. 8, p. 1228, doi. 10.1007/s00259-006-0356-3

By:

de Visser, M.;
Bernard, H. F.;
Erion, J. L.;
Schmidt, M. A.;
Srinivasan, A.;
Waser, B.;
Reubi, J. C.;
Krenning, E. P.;
de Jong, M.

Publication type:

Article

Comparison of [177Lu-DOTA0,Tyr3]octreotate and [177Lu-DOTA0,Tyr3]octreotide: which peptide is preferable for PRRT?

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2006, v. 33, n. 11, p. 1346, doi. 10.1007/s00259-006-0172-9

By:

Esser, J. P.;
Krenning, E. P.;
Teunissen, J. J. M.;
Kooij, P. P. M.;
van Gameren, A. L. H.;
Bakker, W. H.;
Kwekkeboom, D. J.

Publication type:

Article

In vivo radionuclide uptake quantification using a multi-pinhole SPECT system to predict renal function in small animals.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2006, v. 33, n. 10, p. 1214, doi. 10.1007/s00259-006-0178-3

By:

Forrer, F.;
Valkema, R.;
Bernard, B.;
Schramm, N. U.;
Hoppin, J. W.;
Rolleman, E.;
Krenning, E. P.;
de Jong, M.

Publication type:

Article

Stabilised [sup 111]In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 8, p. 1134, doi. 10.1007/s00259-003-1189-y

By:

de Visser, M.;
Janssen, P. J. J. M.;
Srinivasan, A.;
Reubi, J. C.;
Waser, B.;
Erion, J. L.;
Schmidt, M. A.;
Krenning, E. P.;
de Jong, M.

Publication type:

Article

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [[sup 177] Lu-DOTA[sup 0] ,Tyr[sup 3] ]octreotate.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 3, p. 417, doi. 10.1007/s00259-002-1050-8

By:

Kwekkeboom, D. J.;
Bakker, W. H.;
Kam, B. L.;
Teunissen, J. J. M.;
Kooij, P. P. M.;
de Herder, W. W.;
Feelders, R. A.;
van Eijck, C. H. J.;
de Jong, M.;
Srinivasan, A.;
Erion, J. L.;
Krenning, E. P.

Publication type:

Article

Improved Control of Severe Hypoglycemia in Patients with Malignant Insulinomas by Peptide Receptor Radionuclide Therapy.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 11, p. 3381, doi. 10.1210/jc.2011-1563

By:

van Schaik, E.;
van Vliet, E. I.;
Feelders, R. A.;
Krenning, E. P.;
Khan, S.;
Kamp, K.;
Valkema, R.;
van Nederveen, F. H.;
Teunissen, J. J. M.;
Kwekkeboom, D. J.;
de Herder, W. W.

Publication type:

Article

Exercise echocardiography versus thallium-201 SPECT for assessing patients before and after PTCA.

Published in:

European Heart Journal, 1992, v. 13, n. 2, p. 213, doi. 10.1093/oxfordjournals.eurheartj.a060149

By:

FIORETTI, P. M.;
POZZOLI, M. M. A.;
ILMER, B.;
SALUSTRI, A.;
CORNEL, J.-H.;
REUS, A. E. M.;
KRENNING, E. P.;
REIBER, J. H. C.;
DE FEYTER, P. J.;
ROELANDT, J. R. T. C.

Publication type:

Article

Pulmonary clearance of 99mTc-DTPA during halothane anaesthesia.

Published in:

1990

By:

Wollmer, P.;
Schairer, W.;
Bos, J. A. H.;
Barker, W.;
Krenning, E. P.;
Lachmann, B.;
Bos, J A;
Bakker, W

Publication type:

journal article

Estrogen Receptor α Gene Polymorphisms and Bone Mineral Density in Healthy Children and Young Adults ERα Gene Polymorphisms and BMD in Children.

Published in:

Calcified Tissue International, 2004, v. 74, n. 6, p. 495, doi. 10.1007/s00223-003-0168-4

By:

Boot, A. M.;
van der Sluis, I. M.;
Keizer-Schrama, S. M. P. F. de Muinck;
van Meurs, J. B. J.;
Krenning, E. P.;
Pols, H. A. P.;
Uitterlinden, A. G.

Publication type:

Article

Vitamin D Receptor Gene Polymorphism Predicts Height and Bone Size, Rather Than Bone Density in Children and Young Adults.

Published in:

Calcified Tissue International, 2003, v. 73, n. 4, p. 332, doi. 10.1007/s00223-002-2130-2

By:

van der Sluis, I. M.;
de Muinck Keizer-Schrama, S. M. P. F.;
Krenning, E. P.;
Pols, H. A. P.;
Uitterlinden, A. G.

Publication type:

Article

Somatostatin-receptor Scintigraphy in Gastroenteropancreatic Tumors.

Published in:

Annals of the New York Academy of Sciences, 1994, v. 733, n. 1, p. 416, doi. 10.1111/j.1749-6632.1994.tb17291.x

By:

KRENNING, E. P.;
KWEKKEBOOM, D. J.;
OEI, H. Y.;
JONG, R. J. B.;
DOP, F. J.;
REUBI, J. C.;
LAMBERTS, S. W. J.

Publication type:

Article

Radiotherapy with a Radiolabeled Somatostatin Analogue, [111In-DTPA- d-Phe1]-Octreotide.

Published in:

Annals of the New York Academy of Sciences, 1994, v. 733, n. 1, p. 496, doi. 10.1111/j.1749-6632.1994.tb17300.x

By:

KRENNING, E. P.;
KOOIJ, P. P. M.;
BAKKER, W. H.;
BREEMAN, W. A. P.;
POSTEMA, P. T. E.;
KWEKKEBOOM, D. J.;
OEI, H. Y.;
JONG, M.;
VISSER, T. J.;
REIJS, A. E. M.;
LAMBERTS, S. W. J.

Publication type:

Article

The use of an isotope labeled somatostatin analog in the visualization of pancreatic tumors enlarges the indication for operative therapy.

Published in:

HPB Surgery, 1993, v. 6, p. 113

By:

Van Eijck, C. H. J.;
Lamberts, S. W. J.;
Krenning, E. P.;
Jeekel, J.

Publication type:

Article

Cost-Effectiveness Analysis of Somatostatin Receptor Scintigraphy.

Published in:

Journal of Nuclear Medicine, 1996, v. 37, n. 6, p. 886

By:

Kwekkeboom, D. J.;
Lamberts, S. W. J.;
Habbema, J. D. F.;
Krenning, E. P.

Publication type:

Article

Somatostatin Receptor Scintigraphy with Indium-111-DTPA-D-Phe-1-Octreotide in Man: Metabolism, Dosimetry and Comparison with Iodine-123-Tyr-3-Octreotide.

Published in:

Journal of Nuclear Medicine, 1992, v. 33, n. 5, p. 652

By:

Krenning, E. P.;
Bakker, W. H.;
Kooij, P. P. M.;
Breeman, W. A. P.;
Oei, H. Y.;
de Jong, M.;
Reubi, J. C.;
Visser, T. J.;
Bruns, C.;
Kwekkeboom, D. J.;
Reijs, A. E. M.;
van Hagen, P. M.;
Koper, J. W.;
Lamberts, S. W. J.

Publication type:

Article

Works matching AU KRENNING, E. P.

DOTA-NOC, A high affinity ligand of the somatostatin receptor subtypes 2, 3 and 5 for radiotherapy.

In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand.

The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism.

The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle-aged women: associations with serum lipids.

A case of antibody formation against octreotide visualized with.

CELLULAR AND HUMORAL IMMUNITY IN PATIENTS WITH HYPERTHYROID GRAVES' DISEASE BEFORE, DURING AND AFTER ANTITHYROID DRUG TREATMENT.

INHERITED THYROXINE EXCESS: A SERUM ABNORMALITY DUE TO AN INCREASED AFFINITY FOR MODIFIED ALBUMIN.

The effect of etanercept on Graves' ophthalmopathy: a pilot study.

Tumor Response Assessment to Treatment with [177Lu-DOTA0,Tyr3]Octreotate in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Differential Response of Bone Versus Soft Tissue Lesions.

Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours.

Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours.

FDG SPECT in the assessment of myocardial viability.

Salvage peptide receptor radionuclide therapy with [<sup>177</sup>Lu-DOTA,Tyr<sup>3</sup>]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours.

Somatostatin and the immune and haematopoetic system; a review.

in vitro and in vivo detection of somatostatin receptors in human malignant lymphomas.

Somatostatin receptor scintigraphy in the initial staging of Hodgkin's disease.

Somatostatin analogue scintigraphy of malignant lymphomas.

Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts.

Novel <sup>111</sup>In-labelled bombesin analogues for molecular imaging of prostate tumours.

Comparison of [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]octreotate and [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]octreotide: which peptide is preferable for PRRT?

In vivo radionuclide uptake quantification using a multi-pinhole SPECT system to predict renal function in small animals.

Stabilised [sup 111]In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [[sup 177] Lu-DOTA[sup 0] ,Tyr[sup 3] ]octreotate.

Improved Control of Severe Hypoglycemia in Patients with Malignant Insulinomas by Peptide Receptor Radionuclide Therapy.

Exercise echocardiography versus thallium-201 SPECT for assessing patients before and after PTCA.

Pulmonary clearance of 99mTc-DTPA during halothane anaesthesia.

Estrogen Receptor α Gene Polymorphisms and Bone Mineral Density in Healthy Children and Young Adults ERα Gene Polymorphisms and BMD in Children.

Vitamin D Receptor Gene Polymorphism Predicts Height and Bone Size, Rather Than Bone Density in Children and Young Adults.

Somatostatin-receptor Scintigraphy in Gastroenteropancreatic Tumors.

Radiotherapy with a Radiolabeled Somatostatin Analogue, [<sup>111</sup>In-DTPA- d-Phe<sup>1</sup>]-Octreotide.

The use of an isotope labeled somatostatin analog in the visualization of pancreatic tumors enlarges the indication for operative therapy.

Cost-Effectiveness Analysis of Somatostatin Receptor Scintigraphy.

Somatostatin Receptor Scintigraphy with Indium-111-DTPA-D-Phe-1-Octreotide in Man: Metabolism, Dosimetry and Comparison with Iodine-123-Tyr-3-Octreotide.